title: Reply: To PMID 23258530.
authors.affiliation: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
authors.forename: James E
authors.initials: JE
authors.lastname: Everhart
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Wright
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000097:blood* / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D012254:Ribavirin / Q000627:therapeutic use*; D005723:gamma-Glutamyltransferase / Q000097:blood*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha; D011092:Polyethylene Glycols; D012254:Ribavirin; D005723:gamma-Glutamyltransferase
references.citation: Digestion. 2012;86(3):218-27
references.pmid: 22964578
references.citation: Hepatology. 2013 May;57(5):1725-33
references.pmid: 23258530